Exact Mass: 309.21112780000004

Exact Mass Matches: 309.21112780000004

Found 71 metabolites which its exact mass value is equals to given mass value 309.21112780000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Methadone

GlaxoSmithKline brand OF methadone hydrochloride

C21H27NO (309.20925320000003)


A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of morphine. It also has a depressant action on the cough center and may be given to control intractable cough associated with terminal lung cancer. Methadone is also used as part of the treatment of dependence on opioid drugs, although prolonged use of methadone itself may result in dependence. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8112; ORIGINAL_PRECURSOR_SCAN_NO 8110 CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8059; ORIGINAL_PRECURSOR_SCAN_NO 8057 CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8114; ORIGINAL_PRECURSOR_SCAN_NO 8112 CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8021; ORIGINAL_PRECURSOR_SCAN_NO 8016 CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8067; ORIGINAL_PRECURSOR_SCAN_NO 8064 CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8100; ORIGINAL_PRECURSOR_SCAN_NO 8098 N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 2828 CONFIDENCE standard compound; INTERNAL_ID 1628

   

Diphenidol

SmithKline beecham brand OF diphenidol hydrochloride

C21H27NO (309.20925320000003)


Diphenidol is only found in individuals that have used or taken this drug. It is an antiemetic agent used in the treatment of vomiting and vertigo. Diphenidol overdose may result in serious toxicity in children.The mechanism by which diphenidol exerts its antiemetic and antivertigo effects is not precisely known. It is thought to diminish vestibular stimulation and depress labyrinthine function and as an antimuscarinic agent. An action on the medullary chemoreceptive trigger zone may also be involved in the antiemetic effect. Diphenidol has no significant sedative, tranquilizing, or antihistaminic action. It has a weak peripheral anticholinergic effect. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

3-(Diphenylmethoxymethyl)-1-ethylpiperidine hydrochloride

3-(Diphenylmethoxymethyl)-1-ethylpiperidine hydrochloride

C21H27NO (309.20925320000003)


   

(9Z,11E,14Z)-(13S)-hydroperoxyoctadeca-(9,11,14)-trienoate

(9Z,11E,14Z)-(13S)-Hydroperoxyoctadeca-(9,11,14)-trienoic acid

C18H29O4 (309.2065734)


(9z,11e,14z)-(13s)-hydroperoxyoctadeca-(9,11,14)-trienoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (9z,11e,14z)-(13s)-hydroperoxyoctadeca-(9,11,14)-trienoate can be found in a number of food items such as wasabi, european chestnut, savoy cabbage, and prunus (cherry, plum), which makes (9z,11e,14z)-(13s)-hydroperoxyoctadeca-(9,11,14)-trienoate a potential biomarker for the consumption of these food products.

   
   

CJ 13217

(E)-2-(3,7-Dimethyl-2,6-octadienyl)-1,3-dimethyl-4(1H)-quinolinone

C21H27NO (309.20925320000003)


   

Benproperine

Benproperine

C21H27NO (309.20925320000003)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3296

   
   
   
   

1-methyl-2-[(1E,5Z)-1,5-undecadienyl]-4(1H)-quinolone

1-methyl-2-[(1E,5Z)-1,5-undecadienyl]-4(1H)-quinolone

C21H27NO (309.20925320000003)


   
   
   

pseudopteroxazole

pseudopteroxazole

C21H27NO (309.20925320000003)


A natural product found in Pseudopterogorgia elisabethae.

   

methadone

methadone

C21H27NO (309.20925320000003)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   
   

Isomethadone

6-(Dimethylamino)-5-methyl-4,4-diphenyl-3-hexanone

C21H27NO (309.20925320000003)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

N-Boc-1,2,5,6-tetrahydropyridine-4-boronic acid pinacol ester

N-Boc-1,2,5,6-tetrahydropyridine-4-boronic acid pinacol ester

C16H28BNO4 (309.21112780000004)


   

2-(N-Propyl-N-phenethylamino)-5-hydroxytetralin

2-(N-Propyl-N-phenethylamino)-5-hydroxytetralin

C21H27NO (309.20925320000003)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

N-(2,5-dimethylphenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(2,5-dimethylphenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C21H27NO (309.20925320000003)


   

bis(3,5-dimethylphenyl)-[(2R)-pyrrolidin-2-yl]methanol

bis(3,5-dimethylphenyl)-[(2R)-pyrrolidin-2-yl]methanol

C21H27NO (309.20925320000003)


   

Levomethadone

(6R)-6-(dimethylamino)-4,4-diphenylheptan-3-one

C21H27NO (309.20925320000003)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

TERT-BUTYL 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,6-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

TERT-BUTYL 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,6-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

C16H28BNO4 (309.21112780000004)


   

bis(3,5-dimethylphenyl)-[(2S)-pyrrolidin-2-yl]methanol

bis(3,5-dimethylphenyl)-[(2S)-pyrrolidin-2-yl]methanol

C21H27NO (309.20925320000003)


   

5-(4-butylphenyl)-N-cyclopentyl-2-methylpyrimidin-4-amine

5-(4-butylphenyl)-N-cyclopentyl-2-methylpyrimidin-4-amine

C20H27N3 (309.22048620000004)


   

9-[3-(dimethylamino)propyl]-10,10-dimethylanthracen-9-ol

9-[3-(dimethylamino)propyl]-10,10-dimethylanthracen-9-ol

C21H27NO (309.20925320000003)


   

1-(4-butoxyphenyl)-N-(4-butylphenyl)methanimine

1-(4-butoxyphenyl)-N-(4-butylphenyl)methanimine

C21H27NO (309.20925320000003)


   

TERT-BUTYL 6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

TERT-BUTYL 6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

C16H28BNO4 (309.21112780000004)


   

Dextromethadone

Dextromethadone

C21H27NO (309.20925320000003)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D002491 - Central Nervous System Agents > D000700 - Analgesics

   
   
   

(9Z,11E,13S,15Z)-13-Hydroperoxyoctadeca-9,11,15-trienoate

(9Z,11E,13S,15Z)-13-Hydroperoxyoctadeca-9,11,15-trienoate

C18H29O4- (309.2065734)


Conjugate base of (9Z,11E,13S,15Z)-13-hydroperoxyoctadeca-9,11,15-trienoic acid.

   

(9S,10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

(9S,10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

C18H29O4- (309.2065734)


   

(9R,10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

(9R,10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

C18H29O4- (309.2065734)


   

(8E,10S,12Z,15Z)-10-hydroperoxyoctadec-8,12,15-trienoate

(8E,10S,12Z,15Z)-10-hydroperoxyoctadec-8,12,15-trienoate

C18H29O4- (309.2065734)


   

(9Z,11E,13S,14Z)-13-hydroperoxyoctadeca-9,11,14-trienoate

(9Z,11E,13S,14Z)-13-hydroperoxyoctadeca-9,11,14-trienoate

C18H29O4- (309.2065734)


The conjugate base of (9Z,11E,13S,14Z)-13-hydroperoxyoctadeca-9,11,14-trienic acid.

   
   
   

9-gamma-Ketol (linolenic acid)

9-gamma-Ketol (linolenic acid)

C18H29O4- (309.2065734)


   

9S-alpha-ketol (linolenic acid)

9S-alpha-ketol (linolenic acid)

C18H29O4- (309.2065734)


   

9(R)-alpha-ketol (linolenic acid)

9(R)-alpha-ketol (linolenic acid)

C18H29O4- (309.2065734)


   

(9E,11E,14E)-13-hydroperoxyoctadeca-9,11,14-trienoate

(9E,11E,14E)-13-hydroperoxyoctadeca-9,11,14-trienoate

C18H29O4- (309.2065734)


   
   

(9Z,11E,15Z)-13-hydroperoxyoctadecatrienoate

(9Z,11E,15Z)-13-hydroperoxyoctadecatrienoate

C18H29O4- (309.2065734)


   

(R)-2-hydroperoxy-alpha-linolenate

(R)-2-hydroperoxy-alpha-linolenate

C18H29O4- (309.2065734)


A hydroperoxy fatty acid anion that is the conjugate base of (R)-2-hydroperoxy-alpha-linolenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

(10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

C18H29O4- (309.2065734)


   

10-HPO(6,8,12)TrE(1-)

10-HPO(6,8,12)TrE(1-)

C18H29O4- (309.2065734)


A polyunsaturated fatty acid anion that is the conjugate base of 10-HPO(6,8,12)TrE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

10(R)-HPO(6,8,12)TrE(1-)

10(R)-HPO(6,8,12)TrE(1-)

C18H29O4- (309.2065734)


A polyunsaturated fatty acid anion that is the conjugate base of 10(R)-HPO(6,8,12)TrE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

dihydro-ML-236C carboxylate

dihydro-ML-236C carboxylate

C18H29O4- (309.2065734)


   

(9Z,11E,13R,15Z)-13-hydroperoxyoctadecatrienoate

(9Z,11E,13R,15Z)-13-hydroperoxyoctadecatrienoate

C18H29O4- (309.2065734)


   

(9Z,11S,12Z,15Z)-11-hydroperoxyoctadecatrienoate

(9Z,11S,12Z,15Z)-11-hydroperoxyoctadecatrienoate

C18H29O4- (309.2065734)


   

(9Z,11R,12Z,15Z)-11-hydroperoxyoctadecatrienoate

(9Z,11R,12Z,15Z)-11-hydroperoxyoctadecatrienoate

C18H29O4- (309.2065734)


   
   
   
   
   

ketomycolate type-3 (XIII)

ketomycolate type-3 (XIII)

C18H29O4- (309.2065734)


   

5-oxo-18-hydroxy-(6E,8Z)-octadecadienoate

5-oxo-18-hydroxy-(6E,8Z)-octadecadienoate

C18H29O4- (309.2065734)


   

12,13-epoxy-(10R)-hydroxy-(8E,15Z)-octadecadienoate

12,13-epoxy-(10R)-hydroxy-(8E,15Z)-octadecadienoate

C18H29O4- (309.2065734)


   

2-(3-Hydroxybutoxy)-N-(2-(diethylamino)ethyl)-3-pyridinecarboxamide

2-(3-Hydroxybutoxy)-N-(2-(diethylamino)ethyl)-3-pyridinecarboxamide

C16H27N3O3 (309.20523119999996)


   

Difenidol

DIPHENIDOL

C21H27NO (309.20925320000003)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

(1r,3ar,4s,6r)-1,4,7-trimethyl-6-(2-methylprop-1-en-1-yl)-1h,2h,3h,3ah,4h,5h,6h-phenaleno[2,1-d][1,3]oxazole

(1r,3ar,4s,6r)-1,4,7-trimethyl-6-(2-methylprop-1-en-1-yl)-1h,2h,3h,3ah,4h,5h,6h-phenaleno[2,1-d][1,3]oxazole

C21H27NO (309.20925320000003)


   

2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1,3-dimethylquinolin-4-one

2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1,3-dimethylquinolin-4-one

C21H27NO (309.20925320000003)


   

1-[(3ar,4r,5r,7as)-5-[(4e)-5-(pyridin-2-yl)pent-4-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

1-[(3ar,4r,5r,7as)-5-[(4e)-5-(pyridin-2-yl)pent-4-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

C21H27NO (309.20925320000003)


   

1-{5-[5-(pyridin-2-yl)pent-4-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl}ethanone

1-{5-[5-(pyridin-2-yl)pent-4-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl}ethanone

C21H27NO (309.20925320000003)


   

(6s)-6-amino-8-(4-aminocyclohexa-2,5-dien-1-yl)-7-methyl-6-(methylamino)-5-oxooctanoic acid

(6s)-6-amino-8-(4-aminocyclohexa-2,5-dien-1-yl)-7-methyl-6-(methylamino)-5-oxooctanoic acid

C16H27N3O3 (309.20523119999996)


   

1,4,7-trimethyl-6-(2-methylprop-1-en-1-yl)-1h,2h,3h,3ah,4h,5h,6h-phenaleno[2,1-d][1,3]oxazole

1,4,7-trimethyl-6-(2-methylprop-1-en-1-yl)-1h,2h,3h,3ah,4h,5h,6h-phenaleno[2,1-d][1,3]oxazole

C21H27NO (309.20925320000003)


   

1-[(3ar,4r,5s,7as)-5-[(3e)-5-(pyridin-2-yl)pent-3-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

1-[(3ar,4r,5s,7as)-5-[(3e)-5-(pyridin-2-yl)pent-3-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

C21H27NO (309.20925320000003)


   

1-[(3ar,4r,5r,7as)-5-[(3e)-5-(pyridin-2-yl)pent-3-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

1-[(3ar,4r,5r,7as)-5-[(3e)-5-(pyridin-2-yl)pent-3-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

C21H27NO (309.20925320000003)


   

2-(3,7-dimethylocta-2,6-dien-1-yl)-1,3-dimethylquinolin-4-one

2-(3,7-dimethylocta-2,6-dien-1-yl)-1,3-dimethylquinolin-4-one

C21H27NO (309.20925320000003)